Ovid Therapeutics
OVID
Ovid Therapeutics (OVID) news
Recent news
Ovid Therapeutics - promotes Charles Carter to chief financial officer
AInvest Wire · Jul 8, 2026ImportantACI Europe says this marks the first year-on-year drop in passenger traffic at European airports since the post-COVID pandemic recovery began in April 2021
AInvest Wire · Jun 3, 2026Ovid Therapeutics appoints leading physician-scientist and biotech innovator Anna Greka, M.D., Ph.D., to board of directors
AInvest Wire · Jun 3, 2026ImportantForeign-born workers accounted for about 90% of new U.S. jobs created since COVID, according to BLS data
AInvest Wire · Jun 2, 2026ImportantChina’s retail sales grew at their slowest pace since the COVID pandemic: Nikkei
AInvest Wire · May 24, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.